Young Adults With Early-onset Obesity Treated With Semaglutide

NCT05574439 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

246

Enrollment

OTHER

Sponsor class

Conditions

Obesity, Adolescent

Interventions

BEHAVIORAL: TCOC treatment
DRUG: Semaglutide 3 mg/ml
DRUG: Placebo (Semaglutide 3 mg/ml)

Sponsor

Signe Torekov

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]